Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma
Human Pathology Jan 05, 2018
Wang R, et al. - This study was conducted to determine whether or not overexpression of AT-rich interaction domain 4B (ARID4B) predicted poor survival in patients with hepatocellular carcinoma (HCC). ARID4B was shown to act as an oncogene in HCC. Therefore, it could serve as a biomarker for the prognoses of patients with HCC.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
